15th - 17th October 2019
London, UK

What’s On › Speakers

Speakers

Diego Ardigo

R&D Rare Diseases Unit Head, Chiesi & Chairman, Therapies Scientific Committee

IRDiRC

Rik Bleijs

Environmental Risk Assessor, Clinical Gene Therapy Trials

National Institute for Public Health and the Environment (RIVM)

Pedro Campino

Global Regulatory Lead, Gene Therapy

CSL Behring

Jean-Philippe Combal

CEO

Vivet Therapeutics

Gavin Corcoran

Chief R&D Officer

Axovant Sciences

Nick Crabb

Programme Director, Scientific Affairs

NICE

Emily Culme-Seymour

Associate Director, Clinical Sciences

Sangamo Therapeutics

Andeleeb Dahy

Associate Director, Regulatory Affairs

Astellas

Caroline Daly

Director, Patient Advocacy Europe

Sarepta Therapeutics

Marcus Droege

Global Head, RWE & Evidence

AveXis, a Novartis Company

Matthias Hebben

VP, Technology Development

Logicbio Therapeutics

Barrett Katz

CMO

GenSight Biologics

Tony Khoury

Vice President of Technical Services

Project Farma

Sven Kili

Principle

Sven Kili Consulting

Rune Kjeken

Scientific Director, Advanced Therapies, CAT

EMA

Mahesh Kudari

Program Leader, Clinical Development

Orchard Therapeutics

Ian McKay

Innovation Lead, Advanced Therapies

Innovate UK

Christeen Moburg

Senior Director, Patient Advocacy

Sangamo Therapeutics

Samantha Parker

SVP & Chief Patient Access Officer

Lysogene

Marcus Peters

Former CCO

Agilis Biotherapeutics

Lyndsey Scull

VP, Communications

Alliance for Regenerative Medicine (ARM)

Aleš Strancar

CEO

BIA Separations

Jim Thomson

Senior Manager, Market Access & Gene Therapy

Pfizer

Birgitte Volck

President, R&D

AVROBIO

Speaker to be Confirmed

PPD Biotech